These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10508302)

  • 21. Comparison of ferucarbotran-enhanced fluid-attenuated inversion-recovery echo-planar, T2-weighted turbo spin-echo, T2*-weighted gradient-echo, and diffusion-weighted echo-planar imaging for detection of malignant liver lesions.
    Fukukura Y; Kamiyama T; Takumi K; Shindo T; Higashi R; Nakajo M
    J Magn Reson Imaging; 2010 Mar; 31(3):607-16. PubMed ID: 20187203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging.
    Nakayama M; Yamashita Y; Mitsuzaki K; Yi T; Arakawa A; Katahira K; Nakayama Y; Takahashi M
    J Magn Reson Imaging; 2000 Jun; 11(6):647-54. PubMed ID: 10862064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images: implications for tumor characterization.
    van Gansbeke D; Metens TM; Matos C; Nicaise N; Gay F; Raeymaekers H; Struyven J
    J Magn Reson Imaging; 1997; 7(3):482-9. PubMed ID: 9170031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.
    Anzai Y; McLachlan S; Morris M; Saxton R; Lufkin RB
    AJNR Am J Neuroradiol; 1994 Jan; 15(1):87-94. PubMed ID: 7511324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver and spleen enhancement after intravenous injection of carboxydextran magnetite: effect of dose, delay of imaging, and field strength in an ex vivo model.
    Caramella D; Jin XN; Mascalchi M; Agen C; Petruzzi P; Kresse M; Bianucci D; Ceretti E; Semmler W; Bartolozzi C
    MAGMA; 1996; 4(3-4):225-30. PubMed ID: 9220411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs.
    Johansson LO; Nolan MM; Taniuchi M; Fischer SE; Wickline SA; Lorenz CH
    J Cardiovasc Magn Reson; 1999; 1(2):139-43. PubMed ID: 11550346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study.
    Hudgins PA; Anzai Y; Morris MR; Lucas MA
    AJNR Am J Neuroradiol; 2002 Apr; 23(4):649-56. PubMed ID: 11950660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI.
    Canet E; Revel D; Forrat R; Baldy-Porcher C; de Lorgeril M; Sebbag L; Vallee JP; Didier D; Amiel M
    Magn Reson Imaging; 1993; 11(8):1139-45. PubMed ID: 8271900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental study of fast and ultrafast T2-weighted imaging sequences using AMI-25 superparamagnetic iron oxide (SPIO).
    Kurokawa H; Togami I; Tsunoda M; Hiraki Y
    Acta Med Okayama; 2001 Feb; 55(1):41-50. PubMed ID: 11246976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative renal cortical perfusion in human subjects with magnetic resonance imaging using iron-oxide nanoparticles: influence of T1 shortening.
    Morell A; Ahlstrom H; Schoenberg SO; Abildgaard A; Bock M; Bjørnerud A
    Acta Radiol; 2008 Oct; 49(8):955-62. PubMed ID: 18615336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic characterization of focal hepatic lesions: role of ferucarbotran-enhanced dynamic MR imaging using T2-weighted multishot spin-echo echo-planar sequence.
    Hori M; Murakami T; Kim T; Iannaccone R; Abe H; Onishi H; Tomoda K; Catalano C; Passariello R; Nakamura H
    J Magn Reson Imaging; 2006 Apr; 23(4):509-19. PubMed ID: 16523480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a new ultrasmall superparamagnetic iron oxide contrast agent Clariscan, (NC100150) for MRI of renal perfusion: experimental study in an animal model.
    Bachmann R; Conrad R; Kreft B; Luzar O; Block W; Flacke S; Pauleit D; Träber F; Gieseke J; Saebo K; Schild H
    J Magn Reson Imaging; 2002 Aug; 16(2):190-5. PubMed ID: 12203767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of small (Tonan T; Fujimoto K; Azuma S; Ono N; Matsushita S; Kojiro M; Hayabuchi N
    Eur J Radiol; 2007 Oct; 64(1):133-9. PubMed ID: 17408900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasmall superparamagnetic particles of iron oxide (USPIO) MR imaging of infarcted myocardium in pigs.
    Kroft LJ; Doornbos J; van der Geest RJ; van der Laarse A; van der Meulen H; de Roos A
    Magn Reson Imaging; 1998 Sep; 16(7):755-63. PubMed ID: 9811141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of focal hepatic lesions: effects of superparamagnetic iron oxide (AMI-25) on magnetic resonance imaging of the liver using T2-weighted fast spin-echo sequences and gradient-and-spin-echo sequences at 1.0 tesla.
    Jung G; Krahe T; Kugel H; Gieseke J; Walter C; Lackner K
    Invest Radiol; 1998 Feb; 33(2):61-7. PubMed ID: 9493719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging of experimental inflammatory bowel disease: quantitative and qualitative analyses with histopathologic correlation in a rat model using the ultrasmall iron oxide SHU 555 C.
    Frericks BB; Wacker F; Loddenkemper C; Valdeig S; Hotz B; Wolf KJ; Misselwitz B; Kühl A; Hoffmann JC
    Invest Radiol; 2009 Jan; 44(1):23-30. PubMed ID: 18836385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions.
    Mergo PJ; Helmberger T; Nicolas AI; Ros PR
    AJR Am J Roentgenol; 1996 Feb; 166(2):379-84. PubMed ID: 8553952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.